Dramatic Results Seen With Gene Therapy for Age-Related Macular Degeneration

Gene therapy for neovascular age-related macular degeneration (nAMD) showed stable vision and retinal anatomy for up to 5 years, with significant reductions in treatment burden, according to studies presented in Montreal.